Organic compounds -- part of the class 532-570 series – Organic compounds – Nitrogen attached directly or indirectly to the purine ring...
Reexamination Certificate
2006-09-12
2006-09-12
McKenzie, Thomas C. (Department: 1624)
Organic compounds -- part of the class 532-570 series
Organic compounds
Nitrogen attached directly or indirectly to the purine ring...
C544S287000, C544S293000, C544S244000, C514S266200, C514S266210, C514S266220, C514S266230, C514S266240, C514S266300, C514S266400
Reexamination Certificate
active
07105669
ABSTRACT:
A compound of formula (I) or a salt, ester or amide thereof; where X is O, or S, S(O) or S(O)2or NR10where R10is hydrogen or C1-6alkyl, and R1, R2, R3, R4, R5, R6, R7, R8and R9are various specified organic groups. These compounds are inhibitors of aurora 2 kinase, and are useful in the treatment of cancer.
REFERENCES:
patent: WO 96/30347 (1996-10-01), None
patent: WO 98/47541 (1998-10-01), None
patent: 2004/013091 (2004-02-01), None
PCT/GB00/03562 International Search Report.
Keen Nicholas John
Mortlock Andrew Austen
AstraZeneca AB
McKenzie Thomas C.
LandOfFree
Quinazoline derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quinazoline derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinazoline derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3593226